Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2022

View Archived Issues

CRV-431 is a possible treatment approach for ALD

Thrombospondin-1 found to be involved in pathogenesis of acute-on-chronic liver failure

Albireo patents SLC10A1 and/or SLC10A2 inhibitors

Qurient Therapeutics discloses new CDK7 inhibitors

Tuojie Biotech identifies new P2X3 antagonists

Stingray Therapeutics synthesizes ENPP1 inhibitors

Roche discovers new EGFR mutant inhibitors for NSCLC

KLB as a novel druggable target for the prevention of NAFLD

CSF1R inhibition could delay muscular dystrophy progression

Extended funding supports Errium's development of therapeutics for chronic autoimmune diseases

Ildong licenses Twist VHH antibody libraries for antibody discovery in immuno-oncology

China NMPA approves IND for Henlius' anti-TIGIT Fc fusion protein HLX-53

Anti-alpha-1-antitrypsin BMN-349 reverses liver disease in a preclinical model

Sutro Biopharma generates hemiasterlin/TLR agonist dual-conjugate anti-FolR-alpha ADCs

ENT1 inhibitor reverses sporadic Alzheimer's disease in mice

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...